Neural Regeneration Research ›› 2014, Vol. 9 ›› Issue (15): 1422-1424.doi: 10.4103/1673-5374.139456

Previous Articles     Next Articles

Give progesterone a chance

Florencia Labombarda 1,2, Daniel Garcia-Ovejero 3   

  1. 1 Laboratory of Neuroendocrine Biochemistry, Institute of Biology and Experimental Medicine CONICET, Vuelta de Obligado 2490, Buenos Aires, Argentina
    2 Departament of Human Biochemistry, School of Medicine, Buenos Aires University, Paraguay 2155, Buenos Aires, Argentina
    3 Neuroinflammation Laboratory, National Hospital For Paraplegics, (SESCAM), Toledo, Spain
  • Received:2014-07-21 Online:2014-08-12 Published:2014-08-12
  • Contact: Florencia Labombarda, Ph.D., Laboratory of Neuroendocrine Biochemistry, Institute of Biology and Experimental Medicine CONICET, Vuelta de Obligado 2490, Buenos Aires, Argentina and Departament of Human Biochemistry School of Medicine, Buenos Aires University, Paraguay 2155, Buenos Aires, Argentina, florlabombarda@gmail.com.

PDF

662

Abstract:

There is currently no standard pharmacological treatment for spinal cord injury. Here, we suggest that progesterone, a steroid hormone, may be a promising therapeutical candidate as it is already for traumatic brain injury, where it has reached phase II clinical trials. We rely on previous works showing anti-inflammatory, neuroprotective and promyelinating roles for progesterone after spinal cord injury and in our recent paper, in which we demonstrate that progesterone diminishes lesion, preserves white matter integrity and improves locomotor recovery in a clinically relevant model of spinal cord lesion.